7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

BioNexus Gene Lab Corp
(NASDAQ:BGLC) 

BGLC stock logo

BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.

Founded: 2017
Full Time Employees: 27
Sector: Specialty Chemicals
Industry: Basic Materials
Share this website to your friends
BioNexus Gene Lab Corp Days Payable Outstanding ttm (DPO)
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 010.5521.0931.6442.1852.7363.2773.82
BioNexus Gene Lab Corp Days Receivable Outstanding ttm (DSO)
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 013.1226.2439.3652.4865.678.7291.84
BioNexus Gene Lab Corp Days Inventory Outstanding ttm (DIO)
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 06.7513.4920.2426.9833.7340.4747.22
BioNexus Gene Lab Corp Op Cashflow Per Share ttm
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.05-0.04-0.02-0.0100.020.030.04
BioNexus Gene Lab Corp Free Cashflow Per Share ttm
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.07-0.05-0.03-0.02-00.010.030.04
BioNexus Gene Lab Corp Cash Per Share ttm
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.080.160.230.310.390.470.55
BioNexus Gene Lab Corp P/S ratio ttm
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.22.393.594.795.997.188.38
BioNexus Gene Lab Corp (GAAP) P/E ratio ttm
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2,338-2,004-1,670-1,336-1,002-668-3340
BioNexus Gene Lab Corp P/B ratio ttm
202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 022.5245.0467.5690.08112.6135.12157.64
No extra charts and metrics for this ticker.